Skip to main content

Table 1 Patient demographics and clinical characteristics (n = 48)

From: Posttreatment FDG PET/CT in predicting survival of patients with ovarian carcinoma

Characteristic N (range or %)
Median (range) of age at diagnosis (years) 58.0 (35–85)
Median (range) between completion of initial treatment and PET/CT (months) 6 (3–9)
Mean ± SD between completion of initial treatment and PET/CT (months) 5.5 ± 1.9
Median follow-up timea (months) 47.3 (4.56–119.8)
Death events 22 (45.8 %)
Median baseline CA-125 (U/mL) 459 (14–8409)
Median CA-125 at follow-up (U/mL) 23.5 (2–626)
FIGO stage  
 I and II 4 (8.33 %)
 III and IV 43 (89.58 %)
 Unknown 1 (2.08 %)
Histologic type  
 Serous 35 (72.92 %)
 Not serous 12 (25.00 %)
 Unknown 1 (2.08 %)
Tumor grade  
 High 40 (83.33 %)
 Low 2 (4.17 %)
 Unknown 6 (12.50 %)
Residual disease  
 Optimal debulking 32 (66.67 %)
 Suboptimal debulking 3 (6.25 %)
 Unknown 13 (27.08 %)
Initial treatment  
 Surgery 48 (100 %)
 Adjuvant chemotherapy 42 (87.5 %)
 Radiation therapy 0 (0 %)
  1. aMedian follow-up was calculated via reverse Kaplan-Meier method